Country of origin: Russia, Veropharm/Belgorod branch Russia, Ocasa Pharma India
Pharm-Group: Antihypertensives - angiotensin-converting enzyme inhibitors
Manufacturers: Veropharm/Belgorod/Ocasa Pharma (Russia), Veropharm/Belgorod branch (Russia), Ocasa Pharma (India)
International name: Enalapril
Synonyms: Apo-Enalapril, Berlipril 10, Berlipril 20, Berlipril 5, Vazolapril, Vasopren, Invoril, Calpiren, Lerin, Myopril, Olivine, Renipril, Renitek, Ednit, Enazil 10, Enalacor, Enalapril, Enalapril ICN, Enalapril Hexal, Enalapril- Agio, Enalapril-Acri, Enalapril
Dosage forms: 5 mg tablets, 20 mg tablets, 10 mg tablets
Ingredients: Enalapril.
Indications for use: Hypertension, symptomatic arterial hypertension, heart failure, diabetic nephropathy, secondary hyperaldosteronism, Raynaud's disease, scleroderma, complex therapy of myocardial infarction, angina pectoris, chronic renal failure.
Contraindications: Hypersensitivity, pregnancy, breastfeeding, children.
Side effects: Central nervous system depression, depression, ataxia, convulsions, drowsiness or insomnia, peripheral neuropathy, visual impairment, taste, smell, tinnitus, conjunctivitis, lacrimation, hypotension, myocardial infarction, acute cerebrovascular accident (as a consequence of hypotension), disorder heart rhythm (atrial tachy- or bradycardia, atrial fibrillation), orthostatic hypotension, angina attack, thromboembolism of the branches of the pulmonary artery, bronchospasm, dyspnea, nonproductive cough, interstitial pneumonitis, bronchitis and other upper respiratory tract infections, rhinorrhea, stomatitis, xerostomia, glossitis , anorexia, dyspepsia, melena, constipation, pancreatitis, liver dysfunction (cholestatic hepatitis, hepatocellular necrosis), kidney dysfunction, oliguria, urinary tract infections, gynecomastia, impotence, neutropenia, thrombocytopenia, exfoliative dermatitis, toxic epidermal necrolysis, pemphigus, herpes zoster , alopecia, photodermatitis, allergic reactions (Stevens-Johnson syndrome, urticaria, Quincke's edema, anaphylactic shock, etc.).
Interaction: The effects of enalapril are increased by diuretics, antihypertensive drugs, and alcohol. Weaken by estogens, NSAIDs, sympathomimetics. Potassium-sparing diuretics and potassium-containing drugs increase the risk of developing hyperkalemia.
Overdose: Symptoms: hypotension, development of myocardial infarction, acute cerebrovascular accident and thromboembolic complications against the background of a sharp decrease in blood pressure. Treatment: intravenous administration of isotonic sodium chloride solution and symptomatic therapy.
Special instructions: Care must be taken when prescribing the drug to patients on a low-salt or salt-free diet. Before and during treatment, monitoring of blood pressure, renal function, the concentration of transaminases and alkaline phosphatase in the vascular bed is necessary (if their levels increase, treatment is canceled). The drug should be prescribed with caution if renal function is impaired (dose selection should be carried out under the control of enalapril in the blood, since the glomerular filtration rate is inversely proportional to its level in plasma).
Literature: Register of Medicines of Russia 2002.